{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T19:40:45Z","timestamp":1781120445771,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K15808"],"award-info":[{"award-number":["21K15808"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019084","name":"Kobe University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019084","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol Phys Technol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>In lung stereotactic body radiation therapy, optimizing plan quality, including dosimetric quality and plan complexity, is paramount for mitigating adverse effects and enhancing dose delivery accuracy. This study evaluated the plan quality of dynamic conformal arc-based volumetric-modulated arc therapy (d-VMAT) as a simplified VMAT compared to conventional VMAT (c-VMAT) across various prescription isodose lines (PIL) and planning target volume (PTV) sizes. Twenty inoperable non-small cell lung cancer patients were retrospectively analyzed (PTV: 7.6\u201368.7\u00a0cm<jats:sup>3<\/jats:sup>). The prescribed dose comprised 48\u00a0Gy delivered in four fractions, encompassing 95% of the PTV, with the PIL ranging from 60 to 90% in 10% increments, using a 6X-flattening filter-free beam. The d-VMAT and c-VMAT plans were generated for each patient and PIL setting. Dose indices, including the conformity index (CI), gradient index (GI), and plan complexity, were assessed for each plan. The GI of d-VMAT closely mirrored that of c-VMAT at 60% and 70% PIL. Nevertheless, d-VMAT exhibited significantly higher GI values than c-VMAT at 80% and 90% PIL, particularly for smaller PTV sizes. Notably, d-VMAT demonstrated reduced plan complexity across all PIL compared to c-VMAT. Clinically, significant differences in CI and dose coverage between d-VMAT and c-VMAT were not observed across varying PIL settings in the range of 60\u201380%. The dose to the organs at risk with d-VMAT was comparable to that with c-VMAT, except at 90% PIL. In conclusion, the simplification of VMAT treatment plan using d-VMAT demonstrates superior plan quality across various PTV sizes at 60% and 70% PIL.<\/jats:p>","DOI":"10.1007\/s12194-025-00907-0","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T09:21:02Z","timestamp":1746782462000},"page":"547-555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comprehensive plan quality assessment of simplified volumetric-modulated arc therapy for lung stereotactic body radiotherapy"],"prefix":"10.1007","volume":"18","author":[{"given":"Yuya","family":"Tatsuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naritoshi","family":"Mukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Seno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeaki","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"907_CR1","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.ijrobp.2018.11.051","volume":"103","author":"GM Videtic","year":"2019","unstructured":"Videtic GM, Paulus R, Singh AK, et al. Long-term follow-up on NRG oncology RTOG 0915 (NCCTG N0927): a randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2019;103:1077\u201384. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.11.051.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"907_CR2","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ijrobp.2015.07.2278","volume":"93","author":"Y Nagata","year":"2015","unstructured":"Nagata Y, Hiraoka M, Shibata T, et al. Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys. 2015;93:989\u201396. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.07.2278.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"907_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10147-006-0646-6","volume":"12","author":"Y Nagata","year":"2007","unstructured":"Nagata Y, Matsuo Y, Takayama K, et al. Current status of stereotactic body radiotherapy for lung cancer. Int J Clin Oncol. 2007;12:3\u20137. https:\/\/doi.org\/10.1007\/s10147-006-0646-6.","journal-title":"Int J Clin Oncol"},{"key":"907_CR4","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.ijrobp.2009.07.1751","volume":"81","author":"H Onishi","year":"2011","unstructured":"Onishi H, Shirato H, Nagata Y, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys. 2011;81:1352\u20138. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.07.1751.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"907_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/acm2.12764","volume":"21","author":"D Pokhrel","year":"2020","unstructured":"Pokhrel D, Halfman M, Sanford L. FFF-VMAT for SBRT of lung lesions: improves dose coverage at tumor-lung interface compared to flattened beams. J Appl Clin Med Phys. 2020;21:26\u201335. https:\/\/doi.org\/10.1002\/acm2.12764.","journal-title":"J Appl Clin Med Phys"},{"key":"907_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.radonc.2013.04.016","volume":"107","author":"P Navarria","year":"2013","unstructured":"Navarria P, Ascolese AM, Mancosu P, et al. Volumetric modulated arc therapy with flattening filter-free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early-stage non-small cell lung cancer (NSCLC). Radiother Oncol. 2013;107:414\u20138. https:\/\/doi.org\/10.1016\/j.radonc.2013.04.016.","journal-title":"Radiother Oncol"},{"key":"907_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.radonc.2020.09.038","volume":"153","author":"V Hernandez","year":"2020","unstructured":"Hernandez V, Hansen CR, Widesott L, et al. What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plans. Radiother Oncol. 2020;153:26\u201333. https:\/\/doi.org\/10.1016\/j.radonc.2020.09.038.","journal-title":"Radiother Oncol"},{"key":"907_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.13862","volume":"24","author":"J Gotstedt","year":"2023","unstructured":"Gotstedt J, Karlsson A, Back A. Evaluation of measures related to dosimetric uncertainty of VMAT plans. J Appl Clin Med Phys. 2023;24: e13862. https:\/\/doi.org\/10.1002\/acm2.13862.","journal-title":"J Appl Clin Med Phys"},{"issue":"7","key":"907_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/acm2.12656","volume":"20","author":"L Vieillevigne","year":"2019","unstructured":"Vieillevigne L, Khamphan C, Saez J, Hernandez V. On the need for tuning the dosimetric leaf gap for stereotactic treatment plans in the Eclipse treatment planning system. J Appl Clin Med Phys. 2019;20(7):68\u201377. https:\/\/doi.org\/10.1002\/acm2.12656.","journal-title":"J Appl Clin Med Phys"},{"key":"907_CR10","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1118\/1.2436972","volume":"34","author":"J Seco","year":"2007","unstructured":"Seco J, Sharp GC, Turcotte J, et al. Effects of organ motion on IMRT treatments with segments of few monitor units. Med Phys. 2007;34:923\u201334. https:\/\/doi.org\/10.1118\/1.2436972.","journal-title":"Med Phys"},{"key":"907_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/acm2.12264","volume":"19","author":"K Kubo","year":"2018","unstructured":"Kubo K, Monzen H, Tamura M, et al. Minimizing dose variation from the interplay effect in stereotactic radiation therapy using volumetric modulated arc therapy for lung cancer. J Appl Clin Med Phys. 2018;19:121\u20137. https:\/\/doi.org\/10.1002\/acm2.12264.","journal-title":"J Appl Clin Med Phys"},{"key":"907_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejmp.2021.05.019","volume":"87","author":"J Leste","year":"2021","unstructured":"Leste J, Medjahed I, Chauvin M, et al. A study of the interplay effect in radiation therapy using a Monte-Carlo model. Phys Med. 2021;87:73\u201382. https:\/\/doi.org\/10.1016\/j.ejmp.2021.05.019.","journal-title":"Phys Med"},{"key":"907_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmp.2023.102547","volume":"107","author":"S Dufreneix","year":"2023","unstructured":"Dufreneix S, Kirie C, Autret D. Evaluation of stereotactic VMAT lung treatment plans for small moving targets. Phys Med. 2023;107: 102547. https:\/\/doi.org\/10.1016\/j.ejmp.2023.102547.","journal-title":"Phys Med"},{"key":"907_CR14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.ijrobp.2013.03.038","volume":"86","author":"CL Ong","year":"2013","unstructured":"Ong CL, Dahele M, Slotman BJ, et al. Dosimetric impact of the interplay effect during stereotactic lung radiation therapy delivery using flattening filter-free beams and volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys. 2013;86:743\u20138. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.03.038.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"907_CR15","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/aab957","volume":"63","author":"A Edvardsson","year":"2018","unstructured":"Edvardsson A, Nordstrom F, Ceberg C, Ceberg S. Motion-induced interplay effects for VMAT radiotherapy. Phys Med Biol. 2018;63: 085012. https:\/\/doi.org\/10.1088\/1361-6560\/aab957.","journal-title":"Phys Med Biol"},{"key":"907_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ijrobp.2015.09.024","volume":"94","author":"S Takao","year":"2016","unstructured":"Takao S, Miyamoto N, Matsuura T, et al. Intrafractional baseline shift or drift of lung tumor motion during gated radiation therapy with a real-time tumor tracking system. Int J Radiat Oncol Biol Phys. 2016;94:172\u201380. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.09.024.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"907_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/acm2.12878","volume":"21","author":"D Pokhrel","year":"2020","unstructured":"Pokhrel D, Visak J, Sanford L. A novel and clinically useful dynamic conformal arc (DCA)-based VMAT planning technique for lung SBRT. J Appl Clin Med Phys. 2020;21:29\u201338. https:\/\/doi.org\/10.1002\/acm2.12878.","journal-title":"J Appl Clin Med Phys"},{"key":"907_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/acm2.12800","volume":"21","author":"R Bokrantz","year":"2020","unstructured":"Bokrantz R, Wedenberg M, Sandwall P. Dynamic conformal arcs for lung stereotactic body radiation therapy: a comparison with volumetric-modulated arc therapy. J Appl Clin Med Phys. 2020;21:103\u20139. https:\/\/doi.org\/10.1002\/acm2.12800.","journal-title":"J Appl Clin Med Phys"},{"key":"907_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.meddos.2023.11.001","volume":"49","author":"J Darreon","year":"2024","unstructured":"Darreon J, Debnath SBC, Benkreira M, et al. A novel lung SBRT treatment planning: inverse VMAT plan with leaf motion limitation to ensure the irradiation reproducibility of a moving target. Med Dosim. 2024;49:159\u201364. https:\/\/doi.org\/10.1016\/j.meddos.2023.11.001.","journal-title":"Med Dosim"},{"key":"907_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.prro.2011.06.001","volume":"2","author":"Y Oku","year":"2012","unstructured":"Oku Y, Takeda A, Kunieda E, et al. Analysis of suitable prescribed isodose line fitting to planning target volume in stereotactic body radiotherapy using dynamic conformal multiple arc therapy. Pract Radiat Oncol. 2012;2:46\u201353. https:\/\/doi.org\/10.1016\/j.prro.2011.06.001.","journal-title":"Pract Radiat Oncol"},{"key":"907_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13014-018-0965-6","volume":"13","author":"M Chan","year":"2018","unstructured":"Chan M, Wong M, Leung R, Cheung S, Blanck O. Optimizing the prescription isodose level in stereotactic volumetric-modulated arc radiotherapy of lung lesions as a potential for dose de-escalation. Radiat Oncol. 2018;13:24. https:\/\/doi.org\/10.1186\/s13014-018-0965-6.","journal-title":"Radiat Oncol"},{"issue":"Suppl 3","key":"907_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3171\/jns.2000.93.supplement","volume":"93","author":"I Paddick","year":"2000","unstructured":"Paddick I. A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note. J Neurosurg. 2000;93(Suppl 3):219\u201322. https:\/\/doi.org\/10.3171\/jns.2000.93.supplement.","journal-title":"J Neurosurg"},{"key":"907_CR23","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.ijrobp.2008.11.019","volume":"73","author":"Y Xiao","year":"2009","unstructured":"Xiao Y, Papiez L, Paulus R, et al. Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2009;73:1235\u201342. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.11.019.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"907_CR24","doi-asserted-by":"publisher","DOI":"10.1118\/1.4810969","volume":"40","author":"L Masi","year":"2013","unstructured":"Masi L, Doro R, Favuzza V, Cipressi S, Livi L. Impact of plan parameters on the dosimetric accuracy of volumetric modulated arc therapy. Med Phys. 2013;40: 071718. https:\/\/doi.org\/10.1118\/1.4810969.","journal-title":"Med Phys"},{"key":"907_CR25","doi-asserted-by":"publisher","DOI":"10.1118\/1.4798944","volume":"40","author":"C Ding","year":"2013","unstructured":"Ding C, Solberg TD, Hrycushko B, Xing L, Heinzerling J, Timmerman RD. Optimization of normalized prescription isodose selection for stereotactic body radiation therapy: conventional vs robotic linac. Med Phys. 2013;40: 051705. https:\/\/doi.org\/10.1118\/1.4798944.","journal-title":"Med Phys"},{"key":"907_CR26","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s00066-022-01940-3","volume":"198","author":"C Ge","year":"2022","unstructured":"Ge C, Wang H, Chen K, Sun W, Li H, Shi Y. Effect of plan complexity on the dosimetry, delivery accuracy, and interplay effect in lung VMAT SBRT with 6 MV FFF beam. Strahlenther Onkol. 2022;198:744\u201351. https:\/\/doi.org\/10.1007\/s00066-022-01940-3.","journal-title":"Strahlenther Onkol"},{"key":"907_CR27","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00066-018-1264-8","volume":"194","author":"T Gauer","year":"2018","unstructured":"Gauer T, Sothmann T, Blanck O, Petersen C, Werner R. Under-reported dosimetry errors due to interplay effects during VMAT dose delivery in extreme hypofractionated stereotactic radiotherapy. Strahlenther Onkol. 2018;194:570\u20139. https:\/\/doi.org\/10.1007\/s00066-018-1264-8.","journal-title":"Strahlenther Onkol"},{"key":"907_CR28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/acm2.12847","volume":"21","author":"EPS Sande","year":"2020","unstructured":"Sande EPS, Acosta Roa AM, Hellebust TP. Dose deviations induced by respiratory motion for radiotherapy of lung tumors: Impact of CT reconstruction, plan complexity, and fraction size. J Appl Clin Med Phys. 2020;21:68\u201379. https:\/\/doi.org\/10.1002\/acm2.12847.","journal-title":"J Appl Clin Med Phys"}],"container-title":["Radiological Physics and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12194-025-00907-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12194-025-00907-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12194-025-00907-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T08:02:44Z","timestamp":1748073764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12194-025-00907-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["907"],"URL":"https:\/\/doi.org\/10.1007\/s12194-025-00907-0","relation":{},"ISSN":["1865-0333","1865-0341"],"issn-type":[{"value":"1865-0333","type":"print"},{"value":"1865-0341","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"30 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board (IRB No. B230237) at Kobe University Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}